Search Results

You are looking at 41 - 50 of 91 items for :

  • Refine by Access: All Content x
Clear All

classes: classical psychedelics (e.g. Psilocybin, LSD, DMT), entactogens (e.g. MDMA), dissociative anaesthetics (e.g. Ketamine), and atypical hallucinogens (e.g. Ibogaine). Each of these different classes are characterised by unique pharmacological

Open access

subscales. The MEQ-30 has demonstrated sensitivity in assessing the effects of a range of psychedelic compounds, including LSD ( Schmid & Liechti, 2018 ), MDMA ( Lyvers & Meester, 2012 ), psilocybin ( Barrett et al., 2015 ), ayahuasca ( Schenberg, Tofoli

Open access

, DMT, and other substances, as seen in Table 1 . Table 1. Lifetime use of hallucinogens Hallucinogen Mean (SD) Median Range LSD 27.51 (104.99) 1.00 0–1,000 Mushrooms 25.64 (94.08) 5.00 0–1,000 MDMA 19.55 (82.7) 0.00 0–5 DMT 3.66 (11.21) 0.00 0

Open access
Journal of Psychedelic Studies
Authors:
Thaddeus James Camlin
,
Donald Eulert
,
Arthur Thomas Horvath
,
Steven F. Bucky
,
Joseph P. Barsuglia
, and
Martin Polanco

( Depoortere, 1987 ; Marrosu et al., 1995 ; Schneider & Sigg, 1957 ). If an ibogaine protocol is developed and psychotherapy is a part of it, as it is in the MDMA research protocol ( Mithoefer, 2017 ), then it may be worth considering the inclusion of

Open access

, M. T. , Reed , S. , & Aggarwal , R. ( 2020 ). Culturally-informed research design issues in a study for MDMA-assisted psychotherapy for posttraumatic stress disorder . Journal of Psychedelic Studies , 4 ( 1 ), 40 – 50 . https://doi.org/10

Open access

general public [Bachelor's thesis, University of Twente] . http://purl.utwente.nl/essays/82465 . Therapeutic Goods Administration ( 2023 , Feb 3). Change to classification of psilocybin and MDMA to enable prescribing by authorised psychiatrists

Open access
Journal of Psychedelic Studies
Authors:
Sam Elias
,
Stephanie Spivak
,
Alexa Alverez
,
Alejandro Gili Olivares
,
Maria Ferrol
, and
Julian Paul Keenan

, K. H. , Heifets , B. D. , Hibicke , M. , Mitchell , J. , et al. ( 2021 ). Hallucinogens in mental health: Preclinical and clinical studies on LSD, psilocybin, MDMA, and ketamine . The Journal of Neuroscience: The Official Journal of the

Open access
Journal of Psychedelic Studies
Authors:
Neşe Devenot
,
Brian A. Pace
,
Jason Slot
, and
Alan K. Davis

of harm in clinical trials of MDMA. The stakes of adequately communicating these risks to patients is high, especially since P-AT is anticipated as a treatment option for PTSD, which disproportionately impacts historically marginalized groups with

Open access

-schedule psilocybin and MDMA, allowing prescriptions by “authorised psychiatrists” for specific indications (PTSD and treatment-resistant depression, respectively) as of July 1, after an “aggressive” lobbying campaign led by Mind Medicine Australia (MMA) ( Blau

Open access

), lifetime phencyclidine (PCP) use (variable PCPFLAG; 0 = never used, 1 = ever used), lifetime 3,4-methylenedioxymethamphetamine (MDMA/ecstasy) use (variable ECSFLAG for 2013–2014 and ECSTMOFLAG for 2015–2019; 0 = never used, 1 = ever used), and lifetime

Open access